Biohaven Pharma (BHVN) Misses Q2 EPS by 3c
Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($0.78), $0.03 worse than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($0.78), $0.03 worse than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.